“…Fifteen randomized trials were identified, of which six presented a crossover design. All studies were classified as "good quality" by the PEDro scale (Foundation, 2017;Maher, 2000;Maher et al, 2003;Moseley et al, 2002;Paci et al, 2010;Zou et al, 2017). Due to heterogeneity in the use of antidepressants, the findings will be presented according to clusters of these clinical indications (Ehrnrooth et al, 2001;Etzel et al, 1991;Feinmann et al, 1984;Forssell et al, 2004;Maina et al, 2002;Moghadamnia et al, 2009;Mohamed et al, 1997;Movassaghian et al, 2011Movassaghian et al, , 2013Raigrodski, Christensen, et al 2001;Rizzatti-Barbosa et al, 2003;Sardella et al, 2008;Sharav et al, 1987;Tammiala-Salonen & Forssell, 1999).…”